The aim of the project is to investigate the utility of new laboratory markers (TFF3) for making a faster and more accurate diagnosis of necrotizing enterocolitis in preterm born infants and for predicting the course of the disease.
Necrotizing Enterocolitis is an inflammatory disorder that affects approximately 1 in 1000 live births; however, the incidence of the disease increases significantly in premature and low birth weight infants. The mortality rate for this disease is approximately 15-30%.
As part of the project, newborns hospitalized at the Department of Neonatology UCC MUW will be examined. The micro-grant recipients will test urinary TFF3 levels in preterm infants born less than 33 weeks gestation and hospitalized in the neonatology unit until 2 weeks of age. The next stage of the project will be to compare the results obtained in different groups of newborns: with developed NEC, with developed other diseases e.g. sepsis, Hirschsprung's disease, without other diseases.
After conducting preliminary research, the investigators will apply for a grant in NCN OPUS competition.